Studies of cytokine levels in bronchoalveolar fluid lavage from patients with interstitial lung diseases

REFERENCES

• Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765–88.
   PubMed Web of Science ®Google Scholar
• Blaschke E, Eklund A, Hernbrand R. Determina-tion of fibronectin and its degradation products in bronchoalveolar fluid. Scand J Clin Invest 1990; 50: 619–25.
   Google Scholar
• Foucras G, Coudert JD, Coureau C, Guéry J-C. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-13-producing cells in the absence of CD8 T cell activation. J Immunol 2000; 165: 4994–5003.
   Google Scholar
• Khalil N, O'Connor RN, Unruh H, Warren P, Kemp A, Berezny 0, Flanders K, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor beta (TGF-I3) in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1990; 5: 155–62.
   Google Scholar
• Hiwatari N, Shimura S, Yamauchi K, Nara M, Hida W, Shirato K. Significance of elevated procollagen-III-peptide and transforming growth factor-I3 levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis. Tohoku J Exp Med 1997; 181: 285–95.
   PubMed Web of Science ®Google Scholar
• Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Miiller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idoipathic pulmonary fibrosis and sarcoidosis. J Invest Med 1998; 46: 223–31.
   Google Scholar
• Allam M, Martinet N, Gallati H, Vaillant P, Hosang M, Martinet Y. Platelet -derived growth factor AA and AB dimers are present in normal human epithelial lining fluid. Eur Respir J 1993; 6: 1162–68.
   PubMed Web of Science ®Google Scholar
• Ishioka S, Saito T, Hiyama K, Haruta Y, Maeda A, Hozawa S, Inamizu T, Yamakida M. Increased expression of tumor necrosis factor-a, interleukin-6, platelet derived growth factor-B and granulocyte-macrophage colony stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 139–45.
   PubMed Web of Science ®Google Scholar
• Wallace WA, Ramage EA, Lamb D, Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary intersitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101: 436–41.
   PubMed Web of Science ®Google Scholar
• Badgett A, Bonner JC, Brody AR. Interferon-gamma modulates lung macrophage production of PDGF-BB and fibroblast growth. J Lipid Mediat Cell Signal 1996; 13: 89–97.
   Google Scholar
• Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992; 88: 280–7.
   PubMed Web of Science ®Google Scholar
• Wahlström J, Katchar K, Wigzell H, Olerup 0, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcioidosis. Am J Respir Crit Care Med 2001; 163: 115–21.
   Google Scholar
• Reynolds HY. Bronchoalveolar lavage has extended the usefulness of bronchoscopy. Eur Respir Rev 1992; 2: 48–53.
   Google Scholar
• Terho EO. Diagnostic criteria for farmer's lung disease. Am J Ind Med 1986; 10: 329–35.
   Web of Science ®Google Scholar
• Katzenstein A-LA, Myers JF. Clinical relevance of pathologic classification. Am J Resp Crit Care Med 1998; 157: 1301–15.
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos 0, Semenzato G, Sharma OP. ATS/ERS/WASOG Statement on sarcoidosis. Sarcoidosis, Vasc Diffuse Lung Dis 1999; 16: 149–73.
   PubMed Web of Science ®Google Scholar
• Sutinen SRH, Riska H, Backman R, Sutinen SH, Fröseth B. Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic immunocytochemical and biochemical reference values. Resp Med 1995; 89: 85–92.
   Google Scholar
• Fagerudd JA, Groop P-H, Honkanen E, Teppo AM, Grönhagen-Riska C. Urinary excretion of TGF-beta and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int 1997; 52 Suppl. 63: 195–7.
   Google Scholar
• Teppo A-M, Maury CPJ. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987; 33: 2024–7.
   Google Scholar
• Honkanen E, Teppo A-M, Törnroth T, Groop P-H, Grönhagen-Riska C. Urinary transforming growth factor-beta in membranous glomerulo-nephritis. Nephrol Dial Transplant 1997; 2: 2562–8.
   Google Scholar
• Vesaluoma M, Teppo A-M, Grönhagen-Riska C, Tervo T. Platelet-derived growth factor-BB (PDGF-BB) in tear fluid—a potential modulator of corneal wound healing following photorefrac-tive keratectomy. Curr Eye Res 1997; 16: 825–31.
   Google Scholar
• Lalancetta M, Carrier G, Lavioletta M, Ferland S, Rodrique J, Begin R, Cantin A, Cormier Y. Long term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis 1993; 148: 216–21.
   PubMedGoogle Scholar
• Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038–48.
   PubMed Web of Science ®Google Scholar
• Hardy MP, Owczarek CM, Trajanovska S, Liu X, Kola I, Hertzog PJ. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. Blood 2001; 97: 473–82.
   PubMed Web of Science ®Google Scholar
• Denis M, Ghadirian E. Transforming growth factor-I3 is generated in the course of hypersensitivity pneumonitis: contribution to collagen synth-esis. Am J Respir Cell Mol Biol 1992; 7: 156–60.
   PubMed Web of Science ®Google Scholar
• Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 1995; 10: 1876–83.
   Google Scholar
• van Vyve T, Chanez P, Lacosta J-V, Bousquet J, Michel F-B, Godard P. Comparison between bronchial and alveolar samples of broncholo-alveolar lavage fluid in asthma. Chest 1992; 102: 356–61.
   Google Scholar
• Goodrich ME, McGee DW. Preferential enhance-ment of B cell IgA secretion by intestinal epithelial cell derived cytokines and interleukin-2. Immonol Invest 1999; 1: 67–75.
   Google Scholar
• Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Hoogsteden HC, van den Bosch JM. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 1993; 9: 1276–81.
   Google Scholar